Home/Filings/4/0001209191-19-059089
4//SEC Filing

LONGENECKER JOHN P PHD 4

Accession 0001209191-19-059089

CIK 0001396814other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:46 PM ET

Size

12.8 KB

Accession

0001209191-19-059089

Insider Transaction Report

Form 4
Period: 2019-12-02
Transactions
  • Sale

    Common Stock

    2019-12-02$46.13/sh1,300$59,97212,761 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-12-023,1283,736 total
    Exercise: $1.61Exp: 2020-09-02Common Stock (3,128 underlying)
  • Exercise/Conversion

    Common Stock

    2019-12-02$1.61/sh+872$1,40410,933 total
  • Exercise/Conversion

    Common Stock

    2019-12-02$1.61/sh+3,128$5,03614,061 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-12-028720 total
    Exercise: $1.61Exp: 2020-09-02Common Stock (872 underlying)
Footnotes (2)
  • [F1]The option vested as to 25% of the options on September 2, 2011 and vested as to the remaining options in successive equal monthly installments for the subsequent 36 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.
  • [F2]The option vested as to 75% of the options on September 2, 2010 and vested as to the remaining 25% of the options in successive equal monthly installments for the subsequent 12 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001288231

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:46 PM ET
Size
12.8 KB